New 52 Week Low Today

Aptose Biosciences Inc APTO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
3.96UNCH (UNCH)
Volume
3,199
Close
3.96quote price arrow down-0.02 (-0.50%)
Volume
861,256
52 week range
3.85 - 9.00

...

Loading . . .

KEY STATS

  • Open3.98
  • Day High4.05
  • Day Low3.85
  • Prev Close3.98
  • 52 Week High9.00
  • 52 Week High Date05/12/20
  • 52 Week Low3.85
  • 52 Week Low Date02/26/21
  • Market Cap351.89M
  • Shares Out88.86M
  • 10 Day Average Volume0.94M
  • Dividend-
  • Dividend Yield-
  • Beta1.73
  • 1 Year % Change-48.57

RATIOS/PROFITABILITY

  • EPS (TTM)-0.53
  • P/E (TTM)-7.52
  • Fwd P/E (NTM)-5.40
  • EBITDA (MRQ)-48.74M
  • ROE (MRQ)-61.61%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/17/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Aptose Biosciences Inc News

There is no recent news for this security.

Latest APTO News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates that exert activity as stand-alone agents and that enhance the activities of other anticancer agents without causing overlapping toxicities. The Company...
William Rice Ph.D.
Chairman
Gregory Chow CPA
Chief Financial Officer
Address
251 Consumers Rd Suite 1105
North York, ON
M2J 4R3
Canada